您当前的位置: 首页 > 数据库
  • 全部(1880)
  • 腹部手术(323)
  • 胸科手术(41)
  • 血管手术(5)
  • 心脏手术(56)
  • 神经外科(4)
  • 头颈部(35)
  • 骨科(78)
  • 泌尿外科(0)
  • 妇产手术(56)
  • 日间手术(26)
  • 手术室外(0)
  • 创伤和烧伤(0)
  • 非心脏手术(410)
  • 老年(0)
  • 小儿新生儿(126)
  • 特殊患者(42)
  • 未说明手术类型(678)
  • 术前宣教(21)
  • 术前评估(33)
  • 术前用药(15)
  • 术前禁食水(12)
  • 麻醉选择(21)
  • 麻醉用药(10)
  • 术中监测(23)
  • 液体管理(14)
  • 血液保护(3)
  • 体温管理(8)
  • 术后疼痛(43)
  • POD(8)
  • PONV(10)
  • 术后康复(50)
  • 特殊情况(43)
  • 术前肠道准备(9)
Array ( [id] => 563 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/563.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:02 [updatetime] => 2024-01-11 15:13:02 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => It is recommended to use the same indications for ICA and revascularization pre-operatively as in the non-surgical setting.(Evidence: Level C,Recommendation:Class Ⅰ) [laiyuan] => NCS术前有创冠状动脉造影术和血运重建的适应症与非手术条件下的适应症相同。(证据级别:Level B ;推荐强度:Class Ⅰ) [znzldj] => A [_inputtime] => 1704957182 [_updatetime] => 1704957182 [_nrjc] => [_nrsh] => )
推荐意见
NCS术前有创冠状动脉造影术和血运重建的适应症与非手术条件下的适应症相同。(证据级别:Level B ;推荐强度:Class Ⅰ)

It is recommended to use the same indications for ICA and revascularization pre-operatively as in the non-surgical setting.(Evidence: Level C,Recommendation:Class Ⅰ)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 564 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/564.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:02 [updatetime] => 2024-01-11 15:13:02 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => CCTA should be considered to rule out CAD in patients with suspected CCS or biomarker-negative NSTE-ACS in case of low-to-intermediate clinical likelihood of CAD, or in patients unsuitable for non-invasive functional testing undergoing non-urgent, intermediate-, and high-risk NCS(Evidence: Level C,Recommendation:Class IIa) [laiyuan] => 疑似慢性冠状动脉综合征或生物标志物阴性的非st段抬高型急性冠脉综合征,如果临床诊断为冠心病可能性低至中等,或不适合进行无创功能检测的非紧急、中、高危NCS患者应考虑冠状动脉ct血管造影来排除冠心病。(证据级别:Level C ;推荐强度:Class IIa) [znzldj] => A [_inputtime] => 1704957182 [_updatetime] => 1704957182 [_nrjc] => [_nrsh] => )
推荐意见
疑似慢性冠状动脉综合征或生物标志物阴性的非st段抬高型急性冠脉综合征,如果临床诊断为冠心病可能性低至中等,或不适合进行无创功能检测的非紧急、中、高危NCS患者应考虑冠状动脉ct血管造影来排除冠心病。(证据级别:Level C ;推荐强度:Class IIa)

CCTA should be considered to rule out CAD in patients with suspected CCS or biomarker-negative NSTE-ACS in case of low-to-intermediate clinical likelihood of CAD, or in patients unsuitable for non-invasive functional testing undergoing non-urgent, intermediate-, and high-risk NCS(Evidence: Level C,Recommendation:Class IIa)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 565 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/565.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:02 [updatetime] => 2024-01-11 15:13:02 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => Pre-operative ICA may be considered in stable CCS patients undergoing elective surgical CEA.(Evidence: Level B,Recommendation:Class IIb) [laiyuan] => 稳定的慢性冠状动脉综合征患者颈动脉内膜切除手术,可考虑术前行有创冠状动脉造影术。(证据级别:Level B ;推荐强度:Class IIb) [znzldj] => A [_inputtime] => 1704957182 [_updatetime] => 1704957182 [_nrjc] => [_nrsh] => )
推荐意见
稳定的慢性冠状动脉综合征患者颈动脉内膜切除手术,可考虑术前行有创冠状动脉造影术。(证据级别:Level B ;推荐强度:Class IIb)

Pre-operative ICA may be considered in stable CCS patients undergoing elective surgical CEA.(Evidence: Level B,Recommendation:Class IIb)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 566 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/566.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:02 [updatetime] => 2024-01-11 15:13:02 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- or intermediate-risk NCS. (Evidence: Level C,Recommendation:Class III) [laiyuan] => 对于接受低或中风险非心脏手术的稳定慢性冠状动脉综合征患者,不建议常规术前行有创冠状动脉造影术。(证据级别:Level C ;推荐强度:Class III) [znzldj] => A [_inputtime] => 1704957182 [_updatetime] => 1704957182 [_nrjc] => [_nrsh] => )
推荐意见
对于接受低或中风险非心脏手术的稳定慢性冠状动脉综合征患者,不建议常规术前行有创冠状动脉造影术。(证据级别:Level C ;推荐强度:Class III)

Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- or intermediate-risk NCS. (Evidence: Level C,Recommendation:Class III)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 567 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/567.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:02 [updatetime] => 2024-01-11 15:13:02 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => It is recommended to assess cardiorespiratory fitness to estimate peri-operative CV risk in obese patients, with particular attention to those undergoing intermediate- and high-risk NCS.(Evidence: Level B ,Recommendation: Class Ⅰ) [laiyuan] => 推荐评估心肺功能,以估计肥胖患者的围手术期心血管风险,尤其注意接受中危和高危NCS的患者。(证据级别:Level B ;推荐强度:Class Ⅰ) [znzldj] => A [_inputtime] => 1704957182 [_updatetime] => 1704957182 [_nrjc] => [_nrsh] => )
推荐意见
推荐评估心肺功能,以估计肥胖患者的围手术期心血管风险,尤其注意接受中危和高危NCS的患者。(证据级别:Level B ;推荐强度:Class Ⅰ)

It is recommended to assess cardiorespiratory fitness to estimate peri-operative CV risk in obese patients, with particular attention to those undergoing intermediate- and high-risk NCS.(Evidence: Level B ,Recommendation: Class Ⅰ)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 568 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/568.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:02 [updatetime] => 2024-01-11 15:13:02 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => Routine referral for cardiac work-up, coronary angiography, or CPET prior to elective surgery for PAD or AAA is not recommended.(Evidence:Level C,Recommendation:Class Ⅲ) [laiyuan] => 不推荐在外周动脉疾病或腹主动脉瘤择期手术前常规转诊进行心脏检查、冠状动脉造影或心肺运动试验。(证据级别:Level C ;推荐强度:Class Ⅲ) [znzldj] => A [_inputtime] => 1704957182 [_updatetime] => 1704957182 [_nrjc] => [_nrsh] => )
推荐意见
不推荐在外周动脉疾病或腹主动脉瘤择期手术前常规转诊进行心脏检查、冠状动脉造影或心肺运动试验。(证据级别:Level C ;推荐强度:Class Ⅲ)

Routine referral for cardiac work-up, coronary angiography, or CPET prior to elective surgery for PAD or AAA is not recommended.(Evidence:Level C,Recommendation:Class Ⅲ)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 569 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/569.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:02 [updatetime] => 2024-01-11 15:13:02 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.(Evidence:Level B ,Recommendation:Class 1) [laiyuan] => 对于糖尿病或糖代谢紊乱的患者,如果前3个月内未进行术前HbA1c测量,推荐术前测量。如果HbA1c≥8.5%(≥69 mmol/mol),若安全可行,应推迟接受NCS。(证据级别:Level B ;推荐强度:Class Ⅰ) [znzldj] => A [_inputtime] => 1704957182 [_updatetime] => 1704957182 [_nrjc] => [_nrsh] => )
推荐意见
对于糖尿病或糖代谢紊乱的患者,如果前3个月内未进行术前HbA1c测量,推荐术前测量。如果HbA1c≥8.5%(≥69 mmol/mol),若安全可行,应推迟接受NCS。(证据级别:Level B ;推荐强度:Class Ⅰ)

In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.(Evidence:Level B ,Recommendation:Class 1)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 514 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/514.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:01 [updatetime] => 2024-01-11 15:13:01 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => After elective PCI, it is recommended to delay time-sensitive NCS until a minimum of 1 month of DAPT treatment has been given. (Evidence: Level B,Recommendation: Class Ⅰ) [laiyuan] => 择期经皮冠状动脉介入治疗术后,推荐延迟时间敏感的非心脏手术,直至给予至少1个月的双联抗血小板治疗。(证据级别:Level B ;推荐强度:Class Ⅰ) [znzldj] => A [_inputtime] => 1704957181 [_updatetime] => 1704957181 [_nrjc] => [_nrsh] => )
推荐意见
择期经皮冠状动脉介入治疗术后,推荐延迟时间敏感的非心脏手术,直至给予至少1个月的双联抗血小板治疗。(证据级别:Level B ;推荐强度:Class Ⅰ)

After elective PCI, it is recommended to delay time-sensitive NCS until a minimum of 1 month of DAPT treatment has been given. (Evidence: Level B,Recommendation: Class Ⅰ)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 515 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/515.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:01 [updatetime] => 2024-01-11 15:13:01 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => It is recommended to delay elective NCS until 6 months after elective PCI and 12 months after an ACS. (Evidence: Level A,Recommendation: Class Ⅰ) [laiyuan] => 推荐将择期NCS延迟至择期经皮冠状动脉介入治疗后6个月和急性冠脉综合征后12个月。(证据级别:Level A ;推荐强度:Class Ⅰ) [znzldj] => A [_inputtime] => 1704957181 [_updatetime] => 1704957181 [_nrjc] => [_nrsh] => )
推荐意见
推荐将择期NCS延迟至择期经皮冠状动脉介入治疗后6个月和急性冠脉综合征后12个月。(证据级别:Level A ;推荐强度:Class Ⅰ)

It is recommended to delay elective NCS until 6 months after elective PCI and 12 months after an ACS. (Evidence: Level A,Recommendation: Class Ⅰ)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读
Array ( [id] => 516 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/516.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:01 [updatetime] => 2024-01-11 15:13:01 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- and intermediate-risk NCS. (Evidence: Level C,Recommendation: Class Ⅲ) [laiyuan] => 对于接受低风险和中等风险NCS的稳定慢性冠状动脉综合征患者,不推荐进行常规术前侵入性冠状动脉造影。(证据级别:Level C ;推荐强度:Class Ⅲ) [znzldj] => A [_inputtime] => 1704957181 [_updatetime] => 1704957181 [_nrjc] => [_nrsh] => )
推荐意见
对于接受低风险和中等风险NCS的稳定慢性冠状动脉综合征患者,不推荐进行常规术前侵入性冠状动脉造影。(证据级别:Level C ;推荐强度:Class Ⅲ)

Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- and intermediate-risk NCS. (Evidence: Level C,Recommendation: Class Ⅲ)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:European Society of Cardiology

阅读